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Summary
Microorganisms have showed the ability to produce biologically active compounds associated 
with neurotransmission in higher organisms. In particular, serotonin- and melatonin-producing 
microbes are valuable sources for the development of eco-friendly bioproducts. Serotonin and 
melatonin are indoleamines that have received special attention due to their positive effects on 
human health. These biomolecules exert a critical role in several physiological or pathological 
processes, including some mental and neurological disorders. This article includes a review of the 
microbial production of serotonin and melatonin, their functions in microorganisms, and their 
potential uses as therapeutic and/or preventive agents to improve human health. A description of 
the quantification methods employed to detect indoleamines and the evidence found concerning 
their microbial production at lab and industrial scale -for application in biotechnological products- 
is also provided. The microbial ability to synthesize beneficial indoleamines should be further 
studied and harnessed, in order to allow the development of sustainable bioprocesses to produce 
foods and pharmaceuticals for human health.
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Introduction
Microorganisms play a relevant role in the environment and in the different living organisms with 
which they interact. In several ecosystems, the interaction between microorganisms and their host 
depends mainly on the production of different chemicals, some of which are neurochemicals 
(Oleskin et al. 2017). Neurochemicals have been defined as chemical substances that affect the 
function of the nervous system (Heinbockel and Csoka 2019). These compounds, which are 
produced not only by animals but also by plants and microorganisms, play several roles such as 
neurotransmitters, neurohormones, and neuromodulators (Roshchina 2016; Heinbockel and Csoka 
2019).
With respect to microorganisms, some have shown the ability to produce various 
biologically active compounds, which are generally associated with neurotransmission in higher 
organisms (Shishov et al., 2009; Cataldo et al. 2020). These compounds include small molecule 
neurotransmitters such as dopamine, norepinephrine, and epinephrine (catecholamines), serotonin 
(indoleamine), histamine (imidazolamine), and gamma aminobutyric acid, among others. 
Roshchina (2016) proposed the term "biomediators" for these compounds since they are 
considered multifunctional substances that can participate in non-nervous processes in animals, 
plants (Roshchina and Yashin 2014) and microorganisms (Villageliú et al. 2018). In addition, 
microbial ability to produce bioactive compounds mainly related to hormonal functions in humans 
(such as catecholamines and melatonin) has been also reported (Manchester et al. 1995; Lyte 
2013).
Among the neuroactive compounds, some indoleamines (i.e., indole compounds that 
contain an amino group) such us serotonin (5-hydroxytryptamine) and melatonin (N-acetyl-5-
methoxytryptamine) have aroused special interest due to their beneficial functions for living 
beings. These indoleamines have various relevant effects on human health in general, and on 
nervous system in particular (O’Mahony et al. 2015; Tan et al. 2015; O’Leary et al. 2020). The 
development of foods or pharmaceuticals including purified biomolecules from microbial origin is 
an eco-friendly alternative to products containing active ingredients obtained from chemical 
synthesis. In this sense, in the last years, few studies have described the melatonin production, 
mainly by genetically modified microbes (Germann et al. 2016; Luo and Foster, 2019; Luo et al. 
2020). On the other hand, wild-type isolates from fermented foods, plants and environmental 
samples have been described as melatonin and serotonin producers (Al-Hassan et al. 2011; Jiao et 
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developing a sustainable microbial process to obtain these compounds, their precursors and 
derivatives constitutes a promising biotechnological perspective. 
Even though several aspects of indoleamines have been already explored, in the last few 
years a strong interest in them has appeared in different research areas. Studies on this subject that 
allow the identification and harnessing of novel biotechnological potentialities associated with 
possible applications of microbial melatonin and serotonin in beneficial products to human health 
are urgently needed. This review focuses on the microbial sources of serotonin and melatonin and 
their effects on human health. It also provides a summary about the available analytical methods to 
quantify them as well as evidence related with their production at both lab and industrial scale. 
Microbial production of serotonin and melatonin 
Serotonin- and melatonin-producing microorganisms 
More than two decades ago, the ability to synthesize melatonin was demonstrated in several 
photosynthetic microorganisms, such as the bacteria Rhodospirillum rubrum and Erythrobacter 
longus (Manchester et al. 1995; Tilden et al. 1997), and the protist Lingulodinium polyedra 
(formerly Gonyaulax polyedra) (Hardeland et al. 1995). Since then, the in vitro production of 
indoleamines such as serotonin and/or melatonin was evidenced in various prokaryotic and 
eukaryotic microorganisms (Table 1). Some microorganisms were isolated from aquatic 
environments, soils and plants, and other are related to fermented product making processes. 
Yeasts belonging to the genus Saccharomyces and bacteria belonging to the genera 
Geobacillus, Bacillus, and Pseudomonas produced both serotonin and melatonin at different 
concentrations (Al-Hassan et al. 2011; Fernández-Cruz et al. 2016; Jiao et al. 2016; Ma et al. 
2017; Muñiz-Calvo et al. 2019). Moreover, the production of melatonin, but not serotonin, was 
evidenced in cultures of some yeasts of the genera Pichia and Saccharomyces, and bacteria of the 
genera Agrobacterium, Pseudomonas, Variovorax, Bacillus, and Oenococcus (Rodriguez-Naranjo 
et al. 2012; Fernández-Pachón et al. 2014; Jiao et al. 2016).  
Microbial production of melatonin has been well described in fermented drinks like wines, 
mainly produced by yeasts belonging to the genus Saccharomyces (Rodriguez-Naranjo et al. 2012; 
Fernandez-Cruz et al. 2019; Muñiz-Calvo et al. 2019). The relevance of these studies lies in the 
fact that melatonin affects organoleptic properties and other characteristics in fermented products 
(Que et al. 2020). In this sense, Rodriguez-Naranjo et al. (2012) described the synthesis of 
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process. They concluded that melatonin production depended on the concentration of L-tryptophan 
and sugars in the medium and on the microbial growth phase, suggesting that melatonin acts as a 
growth molecule signal in yeasts. Likewise, Fernandez-Cruz et al. (2019) studied the intracellular 
biosynthesis of melatonin in Saccharomyces and non-Saccharomyces wine-yeasts using high 
resolution mass spectrometry to finally identify the presence of tryptophan, melatonin, serotonin, 
N-acetyl-5-hydroxytryptamine and indole-3-acetic acid in their intracellular compartment. 
On the other hand, Jiao et al. (2016) and Ma et al. (2017) described the ability of B. 
amyloliquefaciens SB-9 and P. fluorescens RG11, two endophytic bacterial isolates, to 
biotransform L-tryptophan to produce melatonin. This process caused an increase in endogenous 
levels of melatonin in grapevines and a promotion of their growth. 
Serotonin and melatonin: biosynthesis and catabolism
In microorganisms, plants, animals, and humans, both serotonin and melatonin are synthesized 
from tryptophan (Macchi and Bruce 2004; Kang et al. 2007; Jonnakuty and Gragnoli 2008; Back 
et al. 2016). Since the main pathway for the microbial synthesis of these indoleamines remains 
unresolved, biosynthetic pathways described in humans and plants are reviewed in this item.
In humans, after hydroxylation from L-tryptophan to 5-hydroxy-L-tryptophan by a 
tryptophan 5-hydroxylase, 5-hydroxy-L-tryptophan is transformed into serotonin via aromatic L-
amino acid decarboxylase (Jonnakuty and Gragnoli 2008). For melatonin synthesis, serotonin is 
acetylated to N-acetylserotonin in the presence of serotonin N-acetyltransferase and then N-
acetylserotonin is methylated to melatonin by a hydroxy indole-O-methyltransferase (Figure 1) 
(Macchi and Bruce 2004). In the human body, ninety-five percent of the serotonin is found in the 
gastrointestinal tract, where is produced by gut microorganisms and enterochromaffin cells (Van 
der Leek et al. 2017). Some reports highlighted the key role of human gut-associated 
microorganisms in regulating the biosynthesis of serotonin (Reigstad et al. 2015; Yano et al. 
2015). Reigstad et al. (2015) showed that gut microbiota, through the production of short-chain 
fatty acids, promoted the transcription of tph1 (a gene encoding the tryptophan hydroxylase) in 
enterochromaffin cells, regulating the serotonin production at this level. Likewise, Yano et al. 
(2015) described that indigenous spore-forming bacteria from the gut are relevant regulators of 
host serotonin production.
In plants, tryptophan is converted into tryptamine and, after hydroxylation by a tryptamine 
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have been proposed. In the first one, serotonin is converted to N-acetylserotonin and then into 
melatonin by the action of serotonin N-acetyltransferase and N-acetylserotonin O-
methyltransferase, respectively. In the second, serotonin is transformed into 5-methoxytryptamine 
by N-acetylserotonin O-methyltransferase and then this compound is converted into melatonin by 
a serotonin N-acetyltransferase (Figure 2) (Back et al. 2016).
In microorganisms, the production of amines is due to the decarboxylation of amino acids, 
which allows them to produce energy under stress conditions (Gardini et al. 2016). Even though 
similar enzymes and routes for synthetic pathways described in vertebrates participate in the 
process, it has not yet been completely elucidated whether 5-hydroxy-L-tryptophan (as in animals) 
or tryptamine (as in plants) is converted into serotonin in most of serotonin- and/or melatonin-
producing microorganisms. In the last few years, 5-hydroxytryptophan, serotonin, and N-
acetylserotonin, but not tryptamine, were extracellularly detected in the bacteria B. 
amyloliquefaciens SB-9 and P. fluorescens RG11 (Jiao et al. 2016; Ma et al. 2017). However, in 
the yeast S. cerevisiae QA23, tryptamine was detected as the main serotonin precursor (Muñiz-
Calvo et al. 2019). Moreover, serotonin has been described as turning into N-acetylserotonin or 5-
methoxytryptamine before melatonin microbial biosynthesis (Muñiz-Calvo et al. 2019). 
In comparison with the biosynthetic processes, the catabolism of serotonin and melatonin 
in microorganisms is lees understood. Some amine oxidases (enzymes catalyzing the oxidation of 
several amines such as serotonin) or the genes encoding them were identified in various 
microorganisms (Yagodina et al. 2002; Yano et al. 2015). On the other hand, it has been suggested 
that the melatonin catabolism in bacteria is similar to that described in mitochondria (Tan et al. 
2015). This process involves a pseudoenzymatic mechanism with the action of cytochrome C or 
another iron-containing hemoprotein, which degrades melatonin to N1-acetyl-N2-formyl-5-
methoxykynuramine (Tan et al. 2015). Also, a non-enzymatic process was described to metabolize 
melatonin through the interaction with reactive oxygen and nitrogen species, generating several 
metabolites (Tan et al. 2015).
Currently, little is known about the genetic background involved in the microbial 
biosynthetic and catabolic pathways of serotonin and melatonin. Nevertheless, it has been 
suggested that the expression of the genes encoding the biosynthetic enzymes tryptophan 5-
hydroxylase and serotonin N-acetyltransferase is one of the most relevant factors during melatonin 
production (Tan et al. 2015; Luo et al. 2020). Recently, several genes from bacterial origin were 
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the ddc gene –encoding the aromatic L-amino acid decarboxylase- from Candidatus Koribacter 
versatilis Ellin 345 and Draconibacterium orientale, and aanat gene -encoding the aralkylamine 
N-acetyltransferase- from Streptomyces griseofuscus were assayed (Luo et al. 2020). More studies 
are required to elucidate the complete synthetic and catabolic pathways (including genes, enzymes 
and other implied compounds) of serotonin and melatonin in different prokaryotic and eukaryotic 
microbes.
Physiological role of microbial serotonin and melatonin in microorganisms 
In microorganisms, the main role of biomediators is related to growth, intercellular 
communication, interaction with enemies, morphogenesis, and protection against environmental 
changes. However, in some cases, their production at high doses acts as a defense mechanism, a 
response to a stress conditions, or a source of nutrients (Roshchina 2016; Bisquert et al. 2018). 
The essential biomediator serotonin can participate as an intercellular communication agent 
between microorganisms and has a relevant function in the growth regulation and the development 
of other microbial cells (Roshchina 2016). Millimolar to micromolar concentrations of serotonin 
stimulated the growth and acted as an intercellular communicator to synchronize cell aggregation 
in the yeast Candida guilliermondii, Gram-positive bacteria, including Enterococcus faecalis 
(Strakhovskaya et al. 1993), and Gram-negative bacteria, including E. coli and Rhodospirillum 
rubrum (Oleskin et al. 1998). Moreover, there is evidence that exogenous serotonin favors biofilm 
formation in Pseudomonas aeruginosa strains via quorum sensing (Knecht et al. 2016). Other 
reported functions for this compound are related to its protector role under stressful conditions 
such as UV radiation by transforming 5-hydroxy-L-tryptophan into serotonin (Fraikin et al. 1989).
In unicellular organisms, the original and primary function of melatonin is to act as an 
antioxidant and free radical scavenger (Tan et al. 2015). As an antioxidant, this compound exhibits 
various unique characteristics that differ from classic antioxidants, including its cascade reaction 
with free radicals and its ability to induce itself under moderate oxidative stress. Such 
characteristics make melatonin a powerful antioxidant with an endogenous origin that protects 
organisms from catastrophic oxidative stress (Hardeland et al. 1995; Bisquert et al. 2018). Another 
function that has been related to this compound is its participation in the regulation of circadian 
rhythms in some microorganisms such as human gut bacteria and Lingulodinium polyedra, in 
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In summary, serotonin and melatonin exert crucial effects on microorganisms. 
Consequently, from an evolutionary perspective, all microorganisms should have the capacity to 
produce these indoleamines or other biomediators that serve them for perpetuation. Further studies 
on this subject are necessary to determine the generality of microbial ability to synthesize 
biomediators.
Effects of serotonin and melatonin on human health: current and potential uses as 
therapeutic and/or preventive agents
The role of serotonin and melatonin in mental and neurological disorders
Serotonin has been extensively associated with human well-being (Li et al. 2016). In the central 
nervous system, serotonin plays a vital role as a neurotransmitter and regulates several reactions 
and responses to environmental changes, such as mood, nociception, cognition, impulsivity, 
aggressiveness, eating behavior, and body temperature (O’Mahony et al. 2015). 
Serotonin exhibits a satisfactory antioxidant activity (Purushothaman et al. 2020). 
Moreover, this neurochemical plays a significant role in the modulation of behavior in a wide 
range of psychiatric disorders including depression, anxiety, post-traumatic stress, schizophrenia, 
anorexia nervosa, among others (O’Leary et al. 2020). In some psychiatric diseases, defects in 
synaptic molecular signaling involving serotonergic transmission have been implied (Purves et al. 
2018). In this sense, due primarily to its function as a neurotransmitter, serotonin is a relevant 
pharmacological target in the treatment of certain disorders such as depression and certain anxiety 
disorders (O’Leary et al. 2020). Drugs modifying serotonergic transmission and/or selective 
serotonin receptors are effective (Sharma 2004). For example, some pharmacological agents 
widely recognized for the treatment of several mental disorders are the selective serotonin 
reuptake inhibitors, which could block the reabsorption of this substance in neurons increasing its 
levels in brain (Stein and Stahl 2000). Serotonin is reduced with age, especially in the brain in 
cases of Alzheimer’s disease (Rosales-Corral et al. 2012). Serotonin depletion has been also 
related to neuroinflammation since inflammation process contributes to the depletion of 
tryptophan, which reduces serotonin in the brain (Birner et al. 2017). However, serotonin is 
slightly soluble in aqueous solutions and cannot cross the blood-brain barrier; thus, oral 
administration of serotonin is not capable of regulating its levels in the central nervous system. In 
this sense, other strategies are used to modify the serotonin metabolism in the central nervous 
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or 5-hydroxy-L-tryptophan, which increase plasma and brain serotonin levels (Ravindran and da 
Silva 2013; Dome et al. 2019). 
Another relevant indoleamine with positive effects on human health is melatonin, which is 
mainly produced in the pineal gland and has the ability to regulate the circadian sleep-wake 
rhythm (Castaño et al. 2018). Melatonin is soluble in both lipid and aqueous solutions; thus, when 
orally administered, it can pass through all cell barriers after its absorption from the gut (Erland 
and Saxena 2017). The oral administration of is compound has shown positive effects on people 
with sleep problems or jet lag (Castaño et al. 2018). 
On the other hand, numerous studies have evidenced the ability of melatonin to prevent 
the development and progression of neurodegeneration and/or mitigate some of the symptoms of 
neurodegenerative disorders such as Alzheimer, Parkinson and Huntington (Cardinali, 2019; 
Genario et al. 2019; Tamtaji et al. 2020). Moreover, Genario et al. (2019) summarized the critical 
role of melatonin in these and other central nervous system disorders like insomnia, epilepsy, 
autism, depression, and anxiety. In nervous pathologies, there are differential alterations of 
melatonin in body fluids. For example, melatonin levels significantly decreased in cerebrospinal 
fluid in bipolar disorder, whereas a reduction in major depressive disorder was found in serum 
(Bumb et al. 2016).
The modulation of the inflammatory response plays an essential role in the prevention, 
mitigation, and treatment of several mental and neurological disorders (Rhie et al. 2020). In this 
sense, melatonin combines chronobiotic and cytoprotective properties by modifying the biological 
rhythm and reversing the inflammatory and oxidative damages seen in central nervous system 
pathogenesis (Cardinali, 2019; Genario et al. 2019). Melatonin can remove numerous reactive 
oxygen species or reactive nitrogen species compared to classic antioxidants. The melatonin 
molecule and its secondary and tertiary metabolites are able to neutralize various toxic oxygen 
derivatives through the free radical scavenging cascade (Tan et al. 2015). Besides its scavenging 
activity, melatonin has been shown to elevate the antioxidant enzymes superoxide dismutase, 
glutathione reductase, and catalase (Purushothaman et al. 2020). In this sense, this substance is 
relevant in the treatment of neurodegenerative diseases associated with age since they are related 
to an oxidative damage in the central nervous system (Corpas et al. 2018).
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Serotonin is a bioactive substance that also acts at the peripheral level, modulating intestinal 
function, immune response, differentiation of blood cells, and hemodynamic function (Yabut et al. 
2019). In peripheral sites like gastrointestinal tract, pancreas or blood, serotonin can act as a 
hormone, auto- and/or paracrine factor, or intracellular signaling molecule to regulate, for 
example, the metabolic homeostasis (El-Merahbi et al. 2015). Also, extracellular serotonin could 
be degraded by various cell types like osteoclasts or pancreatic cells, and intracellular metabolites 
of serotonin could also act as signaling compounds (Waku et al. 2010). Due to its beneficial 
functions, serotonin could be employed in different products in order to regulate its normal levels 
in peripheral sites. In addition, the antimycotic effect of serotonin against Aspergillus sp. strains, 
which are the primary cause of fungal infections in immunosuppressed patients, was described 
(Perkhofer et al. 2007). Serotonin negatively affects ergosterol synthesis of Aspergillus sp. strains 
fungal cell membrane integrity and hyphal growth (Perkhofer et al. 2007).
Likewise, serotonin derivatives have a wide range of biological activities. They have been 
associated with an aging inhibitor mechanism due to their potent antioxidant activity (Kang et al. 
2009). For example, the antioxidant activities of feruloylserotonin and 4-coumaroylserotonin are 
stronger than α-tocopherol, a natural antioxidant, and similar to butylhydroxyanisole, a synthetic 
antioxidant (Kang et al. 2009).
With respect to melatonin, in several peripheral sites, it regulates the circadian rhythm of 
different physiological like cardiovascular regulation (Imenshahidi et al. 2020), and also acts as a 
free radical scavenger and a broad-spectrum antioxidant (Manchester et al. 2015). Melatonin can 
also decrease blood pressure in patients with hypertension (Grossman et al., 2006), and 
procoagulant levels in plasma in patients with coronary artery disease (Wirtz et al. 2008). 
Moreover, several clinical studies demonstrated that the ingestion of melatonin produces a 
reduction in the toxicity of chemotherapeutic agents in cancer patients (Palmer et al. 2020). On the 
other hand, experimental models on rats showed that melatonin delays tumorigenesis initiation 
since interactions with DNA-bound carcinogens prevent the accumulation of mutations inside 
cells and the initiation of cancer (Kumar et al. 2017). Melatonin has also the ability to repair 
cellular damage and protect healthy cells (Kumar et al. 2017). Tamtaji et al. (2019) reviewed the 
results of several in vivo and in vitro studies claiming that supplementation with melatonin showed 
a therapeutic alternative for pancreatic cancer. This effect could be associated with the ability of 
melatonin to induce the apoptosis of cancer cells, which involves a broad spectrum of molecular 
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On the other hand, melatonin has been well-described as a coadjuvant treatment in several 
gut diseases by increasing the proliferation of immune cells and the antimicrobial activity of 
intestinal microorganisms (Xu et al. 2019; Ma et al. 2020). Besides, some authors have also 
reported the antibacterial and antifungal effects of melatonin (Kilinçel et al. 2019; Xu et al. 2019). 
The antifungal property of melatonin, which was tested in experimental models using rats infected 
with Candida albicans, showed a reduction in the expression of interleukin-6 (Kilinçel et al. 
2019). Daryani et al. (2018) described melatonin therapeutic effect in the treatment of parasitic 
infections mainly caused by parasitic protozoa, suggesting that melatonin enhances the host 
immune response in infections such as Chagas disease, amoebiasis, giardiasis, and malarial 
infections, among others.
In addition, the use of melatonin as a potential therapeutic or preventive drug against 
various antiviral infections has been proposed (García et al. 2020; Reiter et al. 2020). In particular, 
the multifunctional properties of melatonin (e.g., as an antioxidant, anti-inflammatory, and 
antiviral against some viruses) allow suggesting its use –alone or as complement of other drugs- in 
patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Reiter et 
al. 2020; Zhou et al. 2020). SARS-CoV-2 is the virus responsible for the current complex 
coronavirus disease (COVID-19) pandemic (Guo et al. 2020). COVID‐19 can cause a cytokine 
storm that negatively influences on the adaptive immunity against SARS-CoV-2 infection (Reiter 
et al. 2020). In many cases, a severe septic response occurs, and the death of patients is due to an 
excessive inflammatory reaction (Acuña-Castroviejo et al. 2020). Considering that COVID‐19 
could also negatively affect melatonin synthesis (Grunewald et al. 2020), several studies have 
proposed the use of melatonin as a therapeutic agent. In addition to its powerful anti-inflammatory 
and antioxidant activities, melatonin also shows immunomodulatory properties, and it is able to 
repair the oxidative damage caused in mitochondria as a result of an exaggerated inflammatory 
response (Acuña-Castroviejo et al. 2020; Reiter et al. 2020). However, more studies on the 
therapeutic or preventive action of this substance are required to warrant their safety and efficacy 
in several viral infections, including COVID-19. Figure 3 summarizes the beneficial effects of 
melatonin on human health.
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In this century, medical and economic interest in neuroactive compounds produced by 
microorganisms has increased due to their benefits on human health (Lyte, 2013; Oleskin et al. 
2017). The industrial production of beneficial indoleamines is relevant for their potential inclusion 
in food and pharmaceutical products, such as regulating serotonin and melatonin levels, and in this 
way contribute to the treatment and / or prophylaxis of certain physical and mental disorders 
(O’Mahony et al. 2015; O’Leary et al. 2020). 
Currently, melatonin is used in several products to treat and prevent sleep-related 
problems and jet lag (Erland and Saxena, 2017). In fact, this substance is commonly available as 
commercial dietary and pharmaceutical supplements in many countries (Erland and Saxena, 
2017). At an industrial level, melatonin is commonly produced by chemical synthesis, using 
solvents and toxic catalysts to avoid the viral contamination related to extraction in animal tissues 
(Sun et al. 2016). In contrast, microbial production can be an “eco-friendly” and more sustainable 
alternative to conventional chemical processes (Germann et al. 2016; Luo and Foster, 2019; Luo et 
al. 2020). 
Respecting to the biological production of indoleamines of interest, Germann et al. (2016) 
proposed a novel alternative using a “microbial cell factory” to synthesize melatonin. These 
authors reported the construction and expression of a de novo biosynthesis pathway for melatonin 
using a Saccharomyces cerevisiae strain. After the addition of foreign genes involved in melatonin 
biosynthesis as well as other cofactors that support the pathway, and the modification and 
optimization of fermentation and extraction proceeds, the melatonin production achieved was 14.5 
mg L-1. This production was obtained using a simulated fed-batch system with glucose as the sole 
carbon source. Although this strategy could be a possibility to produce melatonin on an industrial 
scale in future, further studies are still necessary, especially those related to a green and effective 
purification process in order to obtain high melatonin purity. 
Likewise, Luo and Foster (2019) developed and patented a process to optimize a 
“microbial cell factory” for melatonin production and other related compounds. This invention is 
based on recombinant microbial cells of E. coli with heterologous nucleic acid sequences encoding 
a monoxygenase for producing the oxidation of an amino acid in order to obtain melatonin and 
related compounds. Recently, Luo et al. (2020) described a bioprocess to improve the microbial 
production of melatonin using E. coli recombinant cells. After some engineering modifications 
and optimization of fermentation conditions, the maximum melatonin titer achieved after fed-
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strain) using external supplementation of tryptophan, and ∼1000 mg L-1 with only glucose as 
carbon source for tryptophan supply. These findings constitute the basis for the commercial 
production of melatonin using E. coli recombinant strains as a microbial factory.
On the other hand, probiotic microorganisms are currently employed in the United States 
of America (Quantum Nutrition Labs (http://healthline.cc)) for the production of melatonin at 
industrial scale. Nevertheless, detailed information on microbial strains and production processes 
is not readily available, possibly due to industrial property rights. As described above (Table 1), 
the natural ability to synthesize serotonin and melatonin has been evidenced in several 
microorganisms from environments and foods. However, wild-type microorganisms have not been 
yet evaluated as candidates for industrial production of the indoleamines of interest. This is an 
innovative research subject that deserves further studies. 
Quantification methods for melatonin and serotonin
As already mentioned, the production of beneficial indoleamines by microorganisms has gained 
special attention in the recent years. However, sometimes their detection turns difficult due to the 
low quantities produced and the sample characteristics. Thus, the development of rapid and 
effective quantification methods for their detection is crucial.
Some of the first techniques described for indoleamine detection, especially for melatonin, 
are thin layer chromatography (Costantini and Paoli 1998), gas chromatography and mass 
spectroscopy (Best et al. 1993), radioimmunoassay (Van Tassel et al. 2001)  and enzyme-linked 
immunosorbent assay (Maldonado et al. 2009) (Table 2). Although enzyme-linked immunosorbent 
assays are simple, rapid, and low cost, they have the disadvantage of the cross-reactivity between 
other compounds with a similar structure, which traduces in low specificity (Kennaway 2019). In 
the last decade, different cutting-edge methods of analytical chemistry were developed. Most of 
them focus on quantifying indoleamines in human serum, fruits, or fermented products (Table 2). 
Currently, two of the most analytical methods employed to detect melatonin are based on 
liquid chromatography separation coupled with fluorescence (Yin et al. 2016; Albu and Radu 
2018) and mass spectrometry (Wolrab et al. 2016; Fernández-Cruz et al. 2017; Jiang et al. 2019). 
The liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been extensively 
described in different studies to determine the amount of melatonin and serotonin in plants and 
food samples (Özen and Ekşi 2016). Recently, the development of an analytical method allowed 
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extraction to pre-concentrate the sample followed by Ultra high performance liquid 
chromatography (UHPLC) analysis with either fluorescence or mass spectrometer detectors 
(Fracassetti et al. 2019). UHPLC, coupled with mass spectrometry, is commonly employed for 
metabolomics analysis in various biological samples, including those from microbial cultures, 
since it provides higher peak capacity and improved resolution and sensibility in complex samples 
(Fernández-Pachón et al. 2014; Ma et al. 2017; Fernandez-Cruz et al. 2019; Fracassetti et al. 
2020). 
On the other hand, Muñiz-Calvo et al. (2017) have also proposed a voltammetric technique 
directly applied to yeasts for the quantification of indoleamines. This method is based on the 
different electroactive characteristics of the compounds involved which allow distinguishing 
between melatonin, thryptophol, and indole-3-acetic acid. The procedure has shown some 
advantages compared with HPLC methods (Azizoğlu et al. 2017), which are sometimes more 
technically complex and expensive, and provides the analyses of the samples with minimal pre-
treatment and within a short time. However, the main problem is the lower discriminability of the 
method since some voltammetric signals showed coincidence among them (Muñiz-Calvo et al. 
2017).
Morcillo-Parra et al. (2019) proposed using a fluorescent bioassay based on the β-
lactamase enzyme reporter system for detecting melatonin in grape must and wine samples 
comparing the results obtained with LC-MS/MS analysis. The study revealed that this technique is 
suitable for the determination of melatonin content in food samples due to the decrease in LOD 
and quantification limit (LOQ) (LOD and LOQ 0.12 and 0.41 ng mL-1 for wine samples). 
However, the authors highlighted the importance of the extraction method given the interference 
observed in complex matrices such as grape must.
Conclusions
Various prokaryotic and eukaryotic microbes from different origins have the natural ability 
to synthesize beneficial indoleamines such as serotonin and melatonin. In some microorganisms, 
these substances have been associated with functions such as intercellular communication, growth, 
and protection against environmental changes. Since these compounds exert crucial functions in 
microbial cells, the following questions arise: are all microorganisms able to produce these 
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questions, it is possible that beneficial indoleamines production has not been yet evidenced in 
numerous microorganisms.
Even though many aspects of serotonin and melatonin produced by microorganisms have 
already been studied, there are many others that still need further investigation. More omics 
analyses (e.g., metagenomics, metatranscriptomics, metaproteomics and metabolomics) are 
required to identify pathways and key enzymes related to serotonin and melatonin biosynthesis in 
non-genetically modified microbes. Wild-type microorganisms producing high levels of beneficial 
indoleamine should be selected, and the bioprocess conditions should be optimized for potential 
industrial applications. On the other hand, suitable microbial strains providing precursors for 
indoleamines synthesis can be used to construct and/or redesign microbial biosynthetic pathways, 
through the introduction and/or overexpression of biosynthetic genes of serotonin and melatonin 
production (Figure 4). In this sense, several strategies of metabolic engineering and synthetic 
biology, such as homologous recombination and CRISPR-Cas9 technologies, can be applied to 
improve serotonin and melatonin biosynthesis in microorganisms. Microbial cell factories should 
be optimized through successive design-build-test-learn cycles (Luo et al. 2020). These cycles can 
include enzyme and promoter engineering, metabolic flux control, pathway optimization, and 
genome-scale metabolic models, among other strategies (Guan et al. 2020). Moreover, the 
selection of the accurate analytical methodology, taking into account the characteristics of the 
sample analyzed and the limitations of the instruments used, is relevant in the study of these 
biomolecules. In view of all the positive effects of these substances on human health, developing a 
suitable and economically profitable biological process to produce them in higher amounts 
becomes essential. 
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Figure legends
Figure 1 Serotonin and melatonin biosynthesis pathways in humans (modified from Kumar et al. 
(2017) and Yılmaz and Gökmen (2020)).
Figure 2 Serotonin and melatonin synthesis pathways in plants (modified from Kumar et al. 
(2017) and Yılmaz and Gökmen (2020)).
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Figure 4 Strategies of metabolic engineering for serotonin and melatonin biosynthesis. Once the 
biosynthetic pathway is elucidated, the design-build-test-learn cycle can be applied to construct 
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Table 1 Serotonin- and/or melatonin-producing microorganisms from different origins
Origin of 
microorganism Microorganism Indoleamine produced (maximum concentration)* Reference
Protists Lingulodinium polyedra Melatonin (7.26 ± 0.21 ng mg-1 protein) Hardeland et al. (1995)Marine environment
Gram-negative bacteria Erythrobacter longus Melatonin (29.20 ng mg-1 protein) Tilden et al. (1997)
Oil polluted soil Gram-positive bacteria Geobacillus stearothermophilus Serotonin (NA) and melatonin (NA) Al-Hassan et al. (2011)
Bacillus amyloliquefaciens SB-9 Serotonin (3.81 ± 0.46 ng mL-1); melatonin (1.19 ± 0.12 ng mL-1) Jiao et al. (2016)Gram-positive bacteria
Bacillus thuringiensis CS-9 Melatonin (0.53 ng mL-1) Jiao et al. (2016)
Agrobacterium tumefaciens CS-30 Melatonin (0.22 ng mL-1) Jiao et al. (2016)
Variovorax sp. VA-10 Melatonin (NA) Jiao et al. (2016)
Pseudomonas sp. VA-7 Melatonin (NA) Jiao et al. (2016)
Grapevine roots
Gram-negative bacteria
Pseudomonas fluorescens RG11 Serotonin (8.28 ± 0.65 ng mL-1); melatonin (1.32 ± 0.12 ng mL-1) Ma et al. (2017)
Orange fruit Yeasts Pichia kluyveri Melatonin (20.00 ± 2.02 ng mL-1) Fernández-Pachón et al. (2014)
Saccharomyces cerevisiae ARM Melatonin (NA) Rodriguez-Naranjo et al. (2012)
Saccharomyces uvarum S6U Melatonin (NA) Rodriguez-Naranjo et al. (2012)
S. cerevisiae var. bayanus BC Melatonin (NA) Rodriguez-Naranjo et al. (2012)
S. cerevisiae QA23 Serotonin and melatonin (different concentrations)† Muñiz-Calvo et al. (2019)
Yeasts
S. cerevisiae (AROMA WHITE) Serotonin (4.5 ng mL-1); melatonin (0.14 ng mL-1) Fernández-Cruz et al. (2016)
Oenococcus oeni UMB434 Melatonin (0.0036 ± 0.0007 ngT mL-1)‡ Fracassetti et al. (2020)
O. oeni UMB436 Melatonin (0.0022 ± 0.0008 ngT mL-1) Fracassetti et al. (2020)
O. oeni UMB438 Melatonin (0.0027 ± 0.0004 ngT mL-1) Fracassetti et al. (2020)
O. oeni UMB462 (DMS20252T) Melatonin (0.0049 ± 0.0010 ngT mL-1) Fracassetti et al. (2020)
Wine
Gram-positive bacteria
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O. oeni UMB472 Melatonin (0.0078 ± 0.0023 ngT mL-1) Fracassetti et al. (2020)
O. oeni UMB473 Melatonin (0.0013 ± 0.0002 ngT mL-1) Fracassetti et al. (2020) 
O. oeni UMB474 Melatonin (0.0021 ± 0.0005 ngT mL-1) Fracassetti et al. (2020)
O. oeni UMB475 Melatonin (0.0025 ± 0.0013 ngT mL-1) Fracassetti et al. (2020)
O. oeni UMB477 Melatonin (0.0049 ± 0.0007 ngT mL-1) Fracassetti et al. (2020)
*Maximal concentration measured of serotonin and/or melatonin (extracellular production). †Different concentrations depending on culture media and added precursors (Muñiz-
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Table 2 Different quantification methods for indoleamines detection
Quantification method* LOD† and LOQ‡ Indoleamine measured/Sample analyzed Reference
NA Melatonin/Lupin primary roots Arnao and Hernández-Ruiz (2007)
LOD: 0.01 ng mL-1, LOQ: 0.03 ng mL-1 Wines Mercolini et al. (2008)
LOD: 1.1 ng mL-1, LOQ: 2.5 ng mL-1 Melatonin/Infant formula Albu and Radu (2018)
HPLC-FL
LOD: 1.2 ng mL-1, LOQ: 1.4 ng mL-1 Serotonin/Infant formula Albu and Radu (2018)
MEPS-HPLC-FL LOD: 0.02 ng mL-1, LOQ: 0.05 ng mL-1 Melatonin/Grapes, must, wine, grappa Mercolini et al. (2012)
UHPLC-FL LOD: 0.06 to 0.08 ng mL−1, LOQ: NA Melatonin/Plasma, eggs, milk Yin et al. (2016)
LOD: 0.1 ng mL-1, LOQ: 0.5 ng mL-1 Melatonin/Human serum Yang et al. (2002)HPLC-MS/MS
NA Melatonin and serotonin/Cherry fruits and juices Özen and Ekşi (2016)
LOD: 0.006 ng mL-1, LOQ: 0.017 ng mL-1 Melatonin/Human serum Wolrab et al. (2016)
LOD: 0.028 ng mL-1, LOQ: 0.1 ng mL-1 N-acetylserotonin/Human serum Wolrab et al. (2016)
LOD: 0.0047 ng mL-1, LOQ: 0.0144 ng mL-1 Melatonin /Wines Fernández-Cruz et al. (2016)
LOD: 0.006  ng mL-1; LOQ: 0.0204 ng mL-1 Serotonin/Wines Fernández-Cruz et al. (2016)
LOD: 0.0023 ng mL-1; LOQ: 0.018 ng mL-1 Melatonin/Wines Fracassetti et al. (2019)
UHPLC-MS/MS
LOD: 0.030 ng mL-1, LOQ: 0.085 ng mL-1 Melatonin/Wines Gomez et al. (2012)
LOD: 0.017 ng mL-1, LOQ: 0.05 ng mL-1 Melatonin/ Human serum Wolrab et al. (2016)SCF-MS/MS
LOD: 0.006 ng mL-1, LOQ: 0.018 ng mL-1 N-acetylserotonin/Human serum Wolrab et al. (2016)
GC-MS NA Melatonin/Tomatoes fruits Van Tassel et al. (2001)
Immunoprecipitation NA Melatonin/Tomatoes, ginger, marine green macroalga 
Ulva Lactuca
Pape and Luning (2006)
Radioimmunoassay NA Melatonin/Tomato fruits Van Tassel et al. (2001)
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immunosorbent assay
LOD: 0.21 ng mL-1 , LOQ: 0.67 ng mL-1 Melatonin/Grape must Morcillo-Parra et al. (2019)Cell-based fluorescent 
bioassay using β-lactamase 
reporter
LOD: 0.12 ng mL-1, LOQ: 0.41 ng mL-1 Melatonin/Wines Morcillo-Parra et al. (2019)
UHPLC-EC NA Melatonin/Intracellular Saccharomyces strains 
production
Muñiz-Calvo et al. (2017)
DSI-MS LOD: 920 ng mL-1, LOQ: 3940 ng mL-1 Melatonin/Commercial melatonin products Jiang et al. (2019)
Real-time detection by 
FSCV
LOD: 5.56 ng mL-1, LOQ: NA Melatonin/Lymph node slices Hensley et al. (2018)
*HPLC: high performance liquid chromatography. UHPLC: ultra high performance liquid chromatography. GC: gas chromatography. FL: fluorescence detection. MS: mass 
spectrometry. EC: electrochemical detection. DSI: droplet spray ionization. SFC: supercritical fluid chromatography. FSCV: fast-scan cyclic voltammetry. MEPS: miniaturized 
microextraction by packed sorbent. LOD†: limit of detection. LOQ‡: limit of quantification. NA: data not available.
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